Transfer factor in prevention of Burkitt's lymphoma relapses.
| dc.contributor.author | Nkrumah, F.K. | |
| dc.contributor.author | Pizza, G. | |
| dc.contributor.author | Neequaye, J. | |
| dc.contributor.author | Viza, D. | |
| dc.contributor.author | De Vinci, C. | |
| dc.contributor.author | Levine, P.H. | |
| dc.date.accessioned | 2013-06-20T13:32:40Z | |
| dc.date.accessioned | 2017-10-16T13:01:52Z | |
| dc.date.available | 2013-06-20T13:32:40Z | |
| dc.date.available | 2017-10-16T13:01:52Z | |
| dc.date.issued | 1987 | |
| dc.description.abstract | Twenty-two African children with endemic Burkitt's lymphoma entered a study to evaluate the possible efficacy of a transfer factor (TF) with specific activity against Eptein-Barr virus in preventing disease relapses. Five of eleven patients have so far relapsed in the non TF-treated group as against two of eleven in the TF-treated group. The patterns of relapse and observable increased disease free remission duration in the TF-treated group strongly suggest a beneficial effect particularly in the prevention of late relapses. A larger series of patients treated with this specific TF are needed to confirm these observations in endemic Burkitt's lymphoma. | en_US |
| dc.identifier.citation | Nkrumah, F. K., Pizza, G., Neequaye, J., Viza, D., De Vinci, C., & Levine, P. H. (1987). Transfer factor in prevention of Burkitt's lymphoma relapses. Journal of Experimental Pathology, 3(4), 463-469. | en_US |
| dc.identifier.uri | http://197.255.68.203/handle/123456789/3752 | |
| dc.language.iso | en | en_US |
| dc.publisher | Journal of Experimental Pathology | en_US |
| dc.title | Transfer factor in prevention of Burkitt's lymphoma relapses. | en_US |
| dc.type | Article | en_US |